According to reports, a quarter of the world’s population may not be vaccinated with COVID-19 until 2022.
Researchers at the Johns Hopkins Bloomberg School of Public Health reported that more than half of the planned doses were obtained by developed countries such as the United States, Japan and Australia, CNN reported.
Anthony Saw of Johns Hopkins and his colleagues say the county has pre-ordered about 7.5 billion doses, which is sufficient to vaccinate 3.76 billion people.
“A little over half (51%) of these doses go to high-income countries, which make up 14% of the world’s population,” they wrote in a peer-reviewed BMJ Medical Weekly report.
At the time the report was prepared, the United States accounted for one-fifth of the world’s cases of the disease, but had booked 800 million jabs, according to CNN.
The network reported that Japan and Australia, which account for less than 1% of cases, had a billion dose options.
Researchers have predicted that 13 major vaccine makers could be vaccinated with nearly 6 billion courses by the end of next year.
“High-income countries reserve more than half of these vaccine doses from 13 major vaccine manufacturers. Low- and middle-income countries make up more than 85% of the world’s population, but the rest There are, “they write.
“Even if all 13 of these vaccine manufacturers reach their maximum production capacity, at least one-fifth of the world’s population will not have access to the vaccine until 2022,” the researchers added.
One effort to avoid this is COVAX, coordinated by the World Health Organization, the global vaccine initiative Gavi, and the Infectious Disease Control Innovation Coalition.
The group is trying to create a capacity to produce 2 billion vaccines.
“The COVAX facility may play an important role in ensuring access to the Covid-19 vaccine, but the goal of 2 billion doses by the end of 2021 is commercially available to achieve this goal. The pre-vaccine commitment and funding is still lacking, “said So’s team.
COVID-19 vaccine may not reach a quarter of the world by 2022: Report
Source link COVID-19 vaccine may not reach a quarter of the world by 2022: Report